Who Buys Amlodipine from India — 1862 Importers Behind a $11.5B Market
India's amlodipine import market is served by 1862 active buyers who collectively imported $11.5B across 15,000 shipments. B LOGISTIK GMBH (GERMANY) leads with a 93.9% market share, followed by UNICHEM PHARMACEUTICALS (USA) INC. and MYLAN HUNGARY KFT,. The top 5 buyers together control 97.4% of total import value, reflecting a concentrated buyer landscape.
Amlodipine buyer data — 1862 importers · $11.5B market · 15,000 shipmentsTransData Nexus · Indian Customs Data
Top Amlodipine Importers — Ranked by Import Value
B LOGISTIK GMBH (GERMANY) is the leading amlodipine importer from India, holding a 93.9% share of the $11.5B market across 15,000 shipments from 1862 buyers. The top 5 buyers — B LOGISTIK GMBH (GERMANY), UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES), MYLAN HUNGARY KFT, (HUNGARY), ASCEND LABORATORIES LLC (UNITED STATES), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) — collectively control 97.4% of total import value.
Top Amlodipine Buyers & Importers
Ranked by import value · 1862 active buyers · Indian Customs (DGFT) data
May 2026
Top Amlodipine Buyers & Importers — Ranked by Import Value. 1862 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Amlodipine — and from which countries?
Flow of Amlodipine exports from India: each country's share and the named importers behind the numbers
Amlodipine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 98.6% of global Amlodipine imports — led by Germany (94.1%) with a total trade value of $11.5B across 15,000 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany emerges as the first largest importing country, achieving a total trade value of $10.8B through 1,239 shipments. This represents a market share of 94.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• B LOGISTIK GMBH - $10.8B (99.7% of country's total business)
• NEXTPHARMA LOGISTICS GMBH - $9.1M (0.1% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $8.7M, indicating premium pricing strategy compared to the market average of $766.5K.
Germany is a key market for Amlodipine imports, representing 94.1% of total trade value.
Primary Market
Secondary Market
2United States
United States emerges as the second largest importing country, achieving a total trade value of $410.7M through 1,653 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.
The importation of Amlodipine from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like B Logistik GmbH (Germany) and NextPharma Logistics GmbH (Germany) function as intermediaries, procuring large volumes of Amlodipine to supply to pharmacies, hospitals, and other healthcare providers. Their purchasing patterns are characterized by bulk orders to achieve economies of scale and ensure consistent supply chains.
Pharmaceutical Companies: Companies such as Unichem Pharmaceuticals (USA) Inc., Mylan Hungary Kft, and Cipla USA Inc. import Amlodipine for direct distribution or further manufacturing. Their procurement is driven by market demand forecasts and regulatory approvals, often involving substantial quantities to meet production and distribution needs.
Contract Manufacturers: Entities like Ascend Laboratories LLC (United States) and Mylan Pharmaceuticals Inc. (United States) may import Amlodipine as an active pharmaceutical ingredient (API) for formulation into finished dosage forms. Their purchasing behavior is aligned with production schedules and contractual obligations, necessitating reliable and timely deliveries.
Each segment's procurement strategies are influenced by factors such as market demand, regulatory compliance, and supply chain logistics, ensuring the availability of Amlodipine to end-users.
The demand for Amlodipine, a calcium channel blocker used primarily to treat hypertension and angina, is driven by several factors:
Disease Prevalence: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that cardiovascular diseases account for approximately 31% of all global deaths, with hypertension being a significant contributor.
Government Healthcare Programs: Many countries have implemented national health initiatives targeting non-communicable diseases. For instance, India's Hypertension Control Initiative emphasizes the inclusion of Amlodipine in treatment protocols to manage high blood pressure effectively.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines. Countries expanding their healthcare coverage often prioritize the availability of cost-effective treatments like Amlodipine to manage prevalent conditions such as hypertension.
WHO Essential Medicines List Procurement: Amlodipine's inclusion in the WHO Essential Medicines List underscores its importance in basic healthcare systems. This designation encourages countries to procure and provide Amlodipine as part of their standard treatment regimens.
Common Questions — Amlodipine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest amlodipine buyer importing from India?
Based on import volume and value, B LOGISTIK GMBH (GERMANY) leads with $10.8B in imports and a 93.9% market share — the highest of any single amlodipine importer. UNICHEM PHARMACEUTICALS (USA) INC. (UNITED STATES) and MYLAN HUNGARY KFT, (HUNGARY) are the next largest buyers.
QHow many companies buy amlodipine from India?
There are 1862 active amlodipine buyers importing from India, with a combined market of $11.5B across 15,000 shipments to 159 countries. The top 5 buyers hold 97.4% of total import value, while the remaining 1857 buyers handle the other 2.6%.
QWhich countries import the most amlodipine from India?
The top importing countries for amlodipine from India are Germany (94.1%), United States (3.6%), Hungary (0.6%), Netherlands (0.2%), South Africa (0.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of amlodipine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for amlodipine from India?
The average import transaction value for amlodipine from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Amlodipine from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like B Logistik GmbH (Germany) and NextPharma Logistics GmbH (Germany) function as intermediaries, procuring large volumes of Amlodipine to supply to pharmacies, hospitals, and other healthcare providers. Their purchasing patterns are characterized by bulk orders to achieve economies of scale and ensure consistent supply chains.
Pharmaceutical Companies: Companies such as Unichem Pharmaceuticals (USA) Inc., Mylan Hungary Kft, and Cipla USA Inc. import Amlodipine for direct distribution or further manufacturing. Their procurement is driven by market demand forecasts and regulatory approvals, often involving substantial quantities to meet production and distribution needs.
Contract Manufacturers: Entities like Ascend Laboratories LLC (United States) and Mylan Pharmaceuticals Inc. (United States) may import Amlodipine as an active pharmaceutical ingredient (API) for formulation into finished dosage forms. Their purchasing behavior is aligned with production schedules and contractual obligations, necessitating reliable and timely deliveries.
Each segment's procurement strategies are influenced by factors such as market demand, regulatory compliance, and supply chain logistics, ensuring the availability of Amlodipine to end-users.
The demand for Amlodipine, a calcium channel blocker used primarily to treat hypertension and angina, is driven by several factors:
Disease Prevalence: Hypertension is a leading risk factor for cardiovascular diseases globally. The World Health Organization (WHO) reports that cardiovascular diseases account for approximately 31% of all global deaths, with hypertension being a significant contributor.
Government Healthcare Programs: Many countries have implemented national health initiatives targeting non-communicable diseases. For instance, India's Hypertension Control Initiative emphasizes the inclusion of Amlodipine in treatment protocols to manage high blood pressure effectively.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines. Countries expanding their healthcare coverage often prioritize the availability of cost-effective treatments like Amlodipine to manage prevalent conditions such as hypertension.
WHO Essential Medicines List Procurement: Amlodipine's inclusion in the WHO Essential Medicines List underscores its importance in basic healthcare systems. This designation encourages countries to procure and provide Amlodipine as part of their standard treatment regimens.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
3.6%
Top Importers: United States has a diverse importer base, with their top importers including:
• UNICHEM PHARMACEUTICALS (USA) INC. - $264.3M (64.4% of country's total business)
• ASCEND LABORATORIES LLC - $38.0M (9.2% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $32.5M (7.9% of country's total business)
• ASCEND LABOATORIES,LLC C/O UPS - $13.8M (3.4% of country's total business)
• ASCEND LABORATORIES,LLC - $7.0M (1.7% of country's total business)
• Rest of United States's importers - $55.0M (13.4% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $248.4K, indicating competitive pricing strategy compared to the market average of $766.5K.
United States is a key market for Amlodipine imports, representing 3.6% of total trade value.
Primary Market
Secondary Market
3Hungary
Hungary emerges as the third largest importing country, achieving a total trade value of $67.3M through 17 shipments. This represents a market share of 0.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hungary has a diverse importer base, with their top importers including:
• MYLAN HUNGARY KFT, - $66.7M (99.2% of country's total business)
Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $4.0M, indicating premium pricing strategy compared to the market average of $766.5K.
Hungary is a key market for Amlodipine imports, representing 0.6% of total trade value.
Primary Market
Secondary Market
4Netherlands
Netherlands emerges as the fourth largest importing country, achieving a total trade value of $24.9M through 0 shipments. This represents a market share of 0.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $24.9M, indicating premium pricing strategy compared to the market average of $766.5K.
Netherlands is a key market for Amlodipine imports, representing 0.2% of total trade value.
Primary Market
Secondary Market
5South Africa
South Africa emerges as the fifth largest importing country, achieving a total trade value of $16.3M through 0 shipments. This represents a market share of 0.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $16.3M, indicating premium pricing strategy compared to the market average of $766.5K.
South Africa is a key market for Amlodipine imports, representing 0.1% of total trade value.
Primary Market
Secondary Market
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.
Estimated Timeline: Typically 10 to 12 months, subject to FDA review processes.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049072 are generally duty-free.
Hungary:
Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
Import Registration Process: Submission of a marketing authorization application, including comprehensive documentation on the product's quality, safety, and efficacy.
Estimated Timeline: Approximately 6 to 12 months, depending on the application specifics.
Import Tariff/Duty: As an EU member state, Hungary generally applies a 0% import duty on pharmaceutical products under HS Code 30049072.
Import Registration Process: Requires a marketing authorization application, including detailed product information and compliance with EU regulations.
Estimated Timeline: Around 7 to 12 months, subject to regulatory review.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049072 are typically exempt from import duties within the EU.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Submission of a medicine registration application, including data on quality, safety, and efficacy.
Estimated Timeline: Approximately 12 to 24 months, depending on the complexity of the application.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049072 are generally subject to a 0% import duty.
These regulatory frameworks ensure that imported Amlodipine meets the respective countries' standards for safety, efficacy, and quality.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure pharmaceuticals, ensuring competitive pricing and consistent supply. This approach is particularly prevalent in low- and middle-income countries, facilitating the widespread availability of essential medicines like Amlodipine.
With 1,862 buyers across 159 countries, the global market for Amlodipine reflects its critical role in managing cardiovascular health, presenting ongoing opportunities for suppliers to meet this sustained demand.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$766.5K
$10.88 per unit
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.
Estimated Timeline: Typically 10 to 12 months, subject to FDA review processes.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049072 are generally duty-free.
Hungary:
Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
Import Registration Process: Submission of a marketing authorization application, including comprehensive documentation on the product's quality, safety, and efficacy.
Estimated Timeline: Approximately 6 to 12 months, depending on the application specifics.
Import Tariff/Duty: As an EU member state, Hungary generally applies a 0% import duty on pharmaceutical products under HS Code 30049072.
Import Registration Process: Requires a marketing authorization application, including detailed product information and compliance with EU regulations.
Estimated Timeline: Around 7 to 12 months, subject to regulatory review.
Import Tariff/Duty: Pharmaceuticals under HS Code 30049072 are typically exempt from import duties within the EU.
South Africa:
Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
Import Registration Process: Submission of a medicine registration application, including data on quality, safety, and efficacy.
Estimated Timeline: Approximately 12 to 24 months, depending on the complexity of the application.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049072 are generally subject to a 0% import duty.
These regulatory frameworks ensure that imported Amlodipine meets the respective countries' standards for safety, efficacy, and quality.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure pharmaceuticals, ensuring competitive pricing and consistent supply. This approach is particularly prevalent in low- and middle-income countries, facilitating the widespread availability of essential medicines like Amlodipine.
With 1,862 buyers across 159 countries, the global market for Amlodipine reflects its critical role in managing cardiovascular health, presenting ongoing opportunities for suppliers to meet this sustained demand.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 1862 global importers of Amlodipine identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 159 destination countries with market share per buyer calculated from capped values.
